BERGEM·HEALTH
Home Doctors Prof. Dr. Funda Timurkaynak, MD
INFECTIOUS DISEASES u00b7 MEMORIAL BAHu00c7ELIEVLER

Prof. Dr. Funda Timurkaynak, MD

Professor of Infectious Diseases and Clinical Microbiology · Memorial Bahu00e7elievler Hospital
Prof. Dr. Funda Timurkaynak is a senior specialist in Infectious Diseases and Clinical Microbiology at Memorial Bahu00e7elievler Hospital. She earned her medical degree at Gazi University Faculty of Medicine (1993) and completed her sub-specialty in Infectious Diseases and Clinical Microbiology at Gazi University (1998). She joined the faculty of Bau015fkent University in 1998, was promoted to Associate Professor in 2005 and Full Professor in 2011, and served as General Secretary of the Turkish Society of Clinical Microbiology and Infectious Diseases (KLu0130Mu0130K) from 2013 to 2015.
Specialties: Infectious Diseases
30+
years in medicine
25+
years in infectious diseases
KLu0130Mu0130K
former General Secretary
Infectious DiseasesClinical MicrobiologyAdult VaccinationKLu0130Mu0130KHantavirus / Emerging Infections
A BergemHealth coordinator arranges contact with the professor within 24–48 hours on business days.
Direct contract with BergemHealth
CONSULTATION LANGUAGES
TR Turkish · native
EN English · professional
RU Russian · via BergemHealth coordinator
UK Ukrainian · via BergemHealth coordinator
ISTANBUL · 06/2026
EDUCATION & CAREER

Timeline

Career milestones.

1998-2010
Faculty member, Infectious Diseases & Clinical Microbiology
Bau015fkent University, Ankara
2010-recent
Faculty member
Bau015fkent University Istanbul Hospital
recent-present
Head/Specialist, Infectious Diseases & Clinical Microbiology
Memorial Bahu00e7elievler Hospital
PUBLICATIONS

Scientific work

Selected peer-reviewed publications.

  • 2005
    J Antimicrob Chemother
    «Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey»
    · senior author · 337 citations
  • 2006
    Int J Antimicrob Agents
    «In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units»
    · first author
  • 2010
    Clin Microbiol Infect
    «Risk factors for extended-spectrum beta-lactamase positivity in uropathogenic Escherichia coli isolated from community-acquired urinary tract infections»
    · co-author
  • 2018
    J Antimicrob Chemother
    «Impact of the ST101 clone on fatality among patients with colistin-resistant Klebsiella pneumoniae infection»
    · co-author
  • 2016
    J Hosp Infect
    «Healthcare-associated Gram-negative bloodstream infections: antibiotic resistance and predictors of mortality»
    · co-author
  • 2009
    Braz J Infect Dis
    «Bloodstream infections caused by ESBL-producing E. coli and K. pneumoniae: risk factors for multidrug-resistance»
    · co-author
REQUEST

Tell me about your case — I’ll read it personally.

Fill in the short form on the consultation page — diagnosis, preferred timing, attached records. We assemble a tumour board for your case and reply within 4 hours.

Open the consultation form
  • Reply within 4 hours during business hours
  • Confidentiality guaranteed
  • Coordinator-translator inside the doctor’s office
  • Tumour board of 2–3 professors within 72 hours